These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 26083304

  • 1. In silico investigation of PARP-1 catalytic domains in holo and apo states for the design of high-affinity PARP-1 inhibitors.
    Salmas RE, Unlu A, Yurtsever M, Noskov SY, Durdagi S.
    J Enzyme Inhib Med Chem; 2016; 31(1):112-20. PubMed ID: 26083304
    [Abstract] [Full Text] [Related]

  • 2. Identification of novel PARP-1 inhibitors by structure-based virtual screening.
    Hannigan K, Kulkarni SS, Bdzhola VG, Golub AG, Yarmoluk SM, Talele TT.
    Bioorg Med Chem Lett; 2013 Nov 01; 23(21):5790-4. PubMed ID: 24074844
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy.
    Wang YQ, Wang PY, Wang YT, Yang GF, Zhang A, Miao ZH.
    J Med Chem; 2016 Nov 10; 59(21):9575-9598. PubMed ID: 27416328
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Design, synthesis and biological activity of novel molecules designed to target PARP and DNA.
    Goodfellow E, Senhaji Mouhri Z, Williams C, Jean-Claude BJ.
    Bioorg Med Chem Lett; 2017 Feb 01; 27(3):688-694. PubMed ID: 28003142
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Exploring the effect of PARP-1 flexibility in docking studies.
    Antolin AA, Carotti A, Nuti R, Hakkaya A, Camaioni E, Mestres J, Pellicciari R, Macchiarulo A.
    J Mol Graph Model; 2013 Sep 01; 45():192-201. PubMed ID: 24056306
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Crystal structure of the catalytic fragment of murine poly(ADP-ribose) polymerase-2.
    Oliver AW, Amé JC, Roe SM, Good V, de Murcia G, Pearl LH.
    Nucleic Acids Res; 2004 Sep 01; 32(2):456-64. PubMed ID: 14739238
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Discovery of 2-(1-(3-(4-Chloroxyphenyl)-3-oxo- propyl)pyrrolidine-3-yl)-1H-benzo[d]imidazole-4-carboxamide: A Potent Poly(ADP-ribose) Polymerase (PARP) Inhibitor for Treatment of Cancer.
    Min R, Wu W, Wang M, Tang L, Chen D, Zhao H, Zhang C, Jiang Y.
    Molecules; 2019 May 17; 24(10):. PubMed ID: 31108884
    [Abstract] [Full Text] [Related]

  • 19. 2,5-Diketopiperazines: A New Class of Poly(ADP-ribose)polymerase Inhibitors.
    Nilov DK, Yashina KI, Gushchina IV, Zakharenko AL, Sukhanova MV, Lavrik OI, Švedas VK.
    Biochemistry (Mosc); 2018 Feb 17; 83(2):152-158. PubMed ID: 29618301
    [Abstract] [Full Text] [Related]

  • 20. Discovery of quinazoline-2,4(1H,3H)-dione derivatives as novel PARP-1/2 inhibitors: design, synthesis and their antitumor activity.
    Zhou J, Ji M, Yao H, Cao R, Zhao H, Wang X, Chen X, Xu B.
    Org Biomol Chem; 2018 May 02; 16(17):3189-3202. PubMed ID: 29648554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.